Sigilon Announces 1-for-13 Reverse Stock Split
Portfolio Pulse from Benzinga Newsdesk
Sigilon Therapeutics has announced a 1-for-13 reverse stock split, which will reduce the number of outstanding shares and increase the stock price proportionally.

May 22, 2023 | 11:32 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Sigilon Therapeutics' 1-for-13 reverse stock split will reduce the number of outstanding shares and increase the stock price proportionally.
The reverse stock split will reduce the number of outstanding shares, which will increase the stock price proportionally. This action is typically neutral for investors, as the overall value of their holdings remains the same. However, it may make the stock more attractive to institutional investors who prefer higher-priced stocks.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100